Twist Bioscience Corporation
TWST
$120.47
-$4.83-3.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 431.80M | 409.48M | 391.56M | 376.57M | 362.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 431.80M | 409.48M | 391.56M | 376.57M | 362.27M |
| Cost of Revenue | 207.41M | 196.25M | 189.42M | 185.57M | 183.88M |
| Gross Profit | 224.39M | 213.23M | 202.13M | 191.00M | 178.40M |
| SG&A Expenses | 290.29M | 272.95M | 260.54M | 246.98M | 236.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 569.57M | 541.09M | 526.07M | 512.83M | 504.64M |
| Operating Income | -137.77M | -131.61M | -134.51M | -136.26M | -142.37M |
| Income Before Tax | -135.85M | -80.53M | -75.71M | -76.95M | -84.82M |
| Income Tax Expenses | 864.00K | 744.00K | 876.00K | 720.00K | 367.00K |
| Earnings from Continuing Operations | -136.72 | -81.28 | -76.58 | -77.67 | -85.19 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -136.72M | -81.28M | -76.58M | -77.67M | -85.19M |
| EBIT | -137.77M | -131.61M | -134.51M | -136.26M | -142.37M |
| EBITDA | -115.28M | -109.84M | -112.75M | -114.31M | -120.26M |
| EPS Basic | -2.22 | -1.32 | -1.27 | -1.30 | -1.45 |
| Normalized Basic EPS | -1.31 | -1.25 | -1.29 | -1.32 | -1.41 |
| EPS Diluted | -2.22 | -1.33 | -1.28 | -1.31 | -1.46 |
| Normalized Diluted EPS | -1.31 | -1.25 | -1.29 | -1.31 | -1.40 |
| Average Basic Shares Outstanding | 245.61M | 243.20M | 241.15M | 239.23M | 237.36M |
| Average Diluted Shares Outstanding | 245.61M | 244.37M | 242.32M | 240.40M | 238.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |